Editorial: Targeting Protein Post-Translational Modifications (PTMs) for Diagnosis and Treatment of Sepsis

Front Immunol. 2022 Feb 3:13:856146. doi: 10.3389/fimmu.2022.856146. eCollection 2022.

Authors

Panpan Chang^{1

2

3}, Yongqing Li⁴

Affiliations

¹ Trauma Medicine Center, Peking University People's Hospital, Beijing, China.
² Key Laboratory of Trauma and Neural Regeneration, Peking University, Beijing, China.
³ National Center for Trauma Medicine of China, Beijing, China.
⁴ Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.

No abstract available

Keywords: biomarker; diagnosis; protein posttranslational modifications (PTMs); sepsis; treatment.

Publication types

Editorial
Introductory Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
Humans
Protein Processing, Post-Translational*
Sepsis / diagnosis*
Sepsis / therapy*

Substances

Biomarkers

Grants and funding

R01 HL155116/HL/NHLBI NIH HHS/United States